
Sudha Seshadri
Director of the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases · University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Credentials: · · ·
History
PresentGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases Center · University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine

- 1993–1994
1992–1993- 1986–1989
Christian Medical College
1985–1986
Research
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Systematic review or meta-analysis · Nature Genetics · 2013 · 3,516 citations
Stroke · 2011 · 3,053 citations
Systematic review or meta-analysis · Nature Genetics · 2019 · 2,420 citations

207 papers
- PW
124 papers

96 papers
- WL
79 papers

78 papers

69 papers · 1 as a fellow

58 papers

54 papers · 11 as a fellow
Grants
- 2021–2031
South Texas Alzheimer's Disease Research Center
National Institute on Aging · P30
Contact PI · $19.4M · University of Texas Hlth Science Center
- 2018–2031
Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC)
National Institute on Aging · R01
Contact PI · $4.7M · University of Texas Hlth Science Center
- 2025–2030
National Institute on Aging · R13
Contact PI · $100K · University of Texas Hlth Science Center
- 1981–2028
Precursors of Stroke Incidence and Prognosis
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $10M · Boston University Medical Campus
Clinical trials
- 2021–2027
Rapamycin - Effects on Alzheimer's and Cognitive Health
Principal investigator · Active not recruiting · Phase 2
The University of Texas Health Science Center at San Antonio
- 2026–2028
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Site PI · Recruiting · Phase 2
Eli Lilly and Company
- 2025–2030
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals

